Loading...

PALATIN TECHNOLOGIES INC Other Situations 8-K Filing

PLTN

PALATIN TECHNOLOGIES INC

()

2023 8-K

Show Summary

Summary

Collaboration Agreement

Voluntary Delisting

Voluntary Delisting

Trading Suspension

Equity Offerings

Delisting Notice

Positive Study Results

Securities Offering

Warrant Agreement

Quarterly Results

Delisting Notice

Annual Meeting Notice

Annual Meeting of Stockholders

Material Definitive Agreement

Securities Purchase Agreement

Asset Purchase Agreement

Securities Purchase Agreement

Earnings Reports

Delisting Notice

Clinical Development Progra...

Partnership Announcement

Participation in Conference

Annual Meeting of Stockholders

Presentation Announcement

Conference Call Announcement

Webinar Announcement

Equity Distribution Agreement

External Links:

Palatin Technologies, Inc. issued a press release reporting on a poster presentation on its PL9588 melanocortin agonist peptide in reducing intraocular pressure at the Association of Research in Vision and Ophthalmology (ARVO) annual meeting.

AI Assistant

PALATIN TECHNOLOGIES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.